Hypertension: How comorbid disease influences the choice of therapy

Geriatrics

Volumn 54, Issue 8, 1999, Pages 34-44

  Butler, Robert N ^a   August, Phyllis ^b   Ferdinand, Keith C ^c   Phillips, Robert A ^d   Roccella, Edward J ^e  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c XAVIER UNIVERSITY OF LOUISIANA   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; COMORBIDITY; CONGESTIVE HEART FAILURE; DRUG EFFECT; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT OUTCOME; URINE INCONTINENCE;

AGED; ANTIHYPERTENSIVE AGENTS; COMORBIDITY; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; KIDNEY FAILURE; MALE; MYOCARDIAL INFARCTION; URINARY INCONTINENCE;

EID: 0032800718     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Butler RN, August P, Ferdinand KC, Phillips RA, Roccella E. Hypertension: Setting new goals for lower readings. Geriatrics 1999; 54(April):20-36.
2. Butler RN, August P, Ferdinand KC, Phillips RA, Roccella E. Hypertension: Therapeutic approach to weight loss, exercise, and salt intake. Geriatrics 1999; 54(May):42-54.
3. Butler RN, August P, Ferdinand KC, Phillips RA, Roccella E. Hypertension: Drug therapy options for older patients. Geriatrics 1999; 54(July):27-37.
4. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-46.
5. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results from the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265;3255-64.
6. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317:713-20.
7. Staessen JA, Fagard R, Thijs L, et al, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1998; 350:757-64.
8. Stamler J, Stander R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. U.S. population data. Arch Intern Med 1993; 153(5):598-615.
9. Wright JT Jr, Kusek JW, Toto RD, et al. Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) pilot study. Control Clin Trials 1996; Aug. 17(4 suppl):3S-16S.
10. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of beta blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998; 280(7):623-9.
11. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta blockers in elderly survivors of acute myocardial infarction. JAMA 1997; 277(2):115-21.
12. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275:1557-62.
13. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27(5):1214-8.
14. The Digitalis Intervention Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336(8):525-33.
15. Missed opportunities in preventive counseling for cardiovascular disease - United States, 1995. MMWR 1998; 47(5):91-5.